Clinical Trial Update: High-dose Use of rhTPO in CIT Patients [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update evaluating high-dose rhTPO in CIT patients with thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Thrombocytopenia | Phase 4 | Status: UNKNOWN